Surveillance system [NNIS]) definitions for device-associated health care-associated infection, we collected prospective data from 155,358 patients hospitalized in the consortium's hospital ICUs for an aggregate of 923,624 days. Although device utilization in the developing countries' ICUs was remarkably similar to that reported from US ICUs in the CDC's NHSN, rates of device-associated nosocomial infection were markedly higher in the ICUs of the INICC hospitals: the pooled rate of central venous catheter (CVC)-associated bloodstream infections (BSI) in the INICC ICUs, 7.6 per 1000 CVC-days, is nearly 3-fold higher than the 2.0 per 1000 CVC-days reported from comparable US ICUs, and the overall rate of ventilator-associated pneumonia (VAP) was also far higher, 13.6 versus 3.3 per 1000 ventilator-days, respectively, as was the rate of catheter-associated urinary tract infection (CAUTI), 6.3 versus 3.3 per 1000 catheter-days, respectively. Most strikingly, the frequencies of resistance of Staphylococcus aureus isolates to methicillin (MRSA) (84.1% vs 56.8%, respectively), Klebsiella pneumoniae to ceftazidime or ceftriaxone (76.1% vs 27.1%, respectively), Acinetobacter baumannii to imipenem (46.3% vs 29.2%, respectively), and Pseudomonas aeruginosa to piperacillin (78.0% vs 20.2%, respectively) were also far higher in the consortium's ICUs, and the crude unadjusted excess mortalities of device-related infections ranged from 23.6% (CVC-associated bloodstream infections) to 29.3% (VAP).
This report is a summary of data on device-associated infections (DAI) within intensive care units (ICUs) collected by hospitals participating in the International Nosocomial Infection Control Consortium (INICC) [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] between January 2003 and December 2008.
The INICC is an international nonprofit, open, multicenter, collaborative health care-associated infection control program with a surveillance system based on that of the US National Healthcare Safety Network (NHSN; formerly the National Nosocomial Infection Surveillance system [NNIS] ). 3 Founded in Argentina in 1998, the INICC is the first multinational research network established to control and reduce DAI through the analysis of data collected on a voluntary basis by a pool of hospitals worldwide. The INICC has the following goals: Create a dynamic global network of hospitals in the developing world that conducts surveillance of health care-associated infections (HAIs) using standardized definitions and established methodologies, promote implementation of evidence-based infection control practices, and carry out applied infection control research; provide training and surveillance tools to individual hospitals that can allow them to conduct outcome and process surveillance of HAIs, measure their consequences, and assess the impact of infection control practices; to improve the safety and quality of health care worldwide through implementation of systematized programs to reduce rates of HAI, associated mortality, excess lengths of stay, excess costs, and bacterial resistance.
METHODS
The INICC at this time has focused on surveillance and prevention of DAI in adult and pediatric ICUs and highrisk nurseries. 3 The data are collected using standardized CDC NNIS/NHSN protocols and definitions. [14] [15] [16] The INICC has both outcome surveillance and process surveillance components. The modules of the components may be used singly or simultaneously, but, once selected, they must be used for a minimum of 1 calendar month.
All DAIs of the Outcome Surveillance Component, are categorized using standard CDC NNIS definitions that include laboratory and clinical criteria. Both laboratory-confirmed bloodstream infections (BSIs) and clinical sepsis without microbiologic confirmation of BSI are recorded and reported. 15 Within the Outcome Surveillance Component, data are classified into specific module protocols addressing the following: DAI rates: excess length of stay, evaluation of HAI costs, crude excess mortality, microbiologic profile, bacterial resistance, and antimicrobial-use data. In addition, INICC methodology includes a process for adjudication of and validation of reported HAIs. 3 Infection control professionals (ICPs) collect data on central line-associated primary bloodstream infections (CLABs), catheter-associated urinary tract infections (CAUTIs), and ventilator-associated pneumonias (VAPs) occurring in patients hospitalized in a specific patient care location, in nearly all hospitals. ICUs are stratified according to the patient population: adult, pediatric, or neonatal units (NICUs).
All NICUs are level III or level II/III units, and ICPs collect data on CLABs and umbilical catheter-associated primary BSIs or VAPs for each of 5 birth-weight categories (,750 g, 750-1000 g, 1001-1500 g, 1501-2500 g, .2500 g). Corresponding denominator data, patient-days, and specific device-days are also collected.
Small proportion of hospitals, with previous longlasting experience conducting surveillance of DAIs, sent aggregated data to the INICC. Original and aggregated data were collected to calculate DAI rates. Only original data were collected to calculate mortality and lengh of stay.
The Process Surveillance Component includes the following modules: hand hygiene compliance monitoring in ICUs; central and peripheral vascular catheter care compliance monitoring; urinary catheter care compliance monitoring; monitoring of compliance with measures to prevent VAP; and performance feedback. Data from the Process Surveillance Module on hand hygiene compliance are included in this report. The identity of all INICC hospitals, cities, and countries is confidential, in accordance with the INICC charter.
RESULTS
Characteristics of 173 ICUs from 25 countries in Latin America, Asia, Africa, and Europe currently participating in the INICC that contributed data for this report are shown in Table 1 . The participation of hospitals on the INICC Program is as follows: mean length of participation 6 SD, 22.9 6 21.6 months, range 1 to 72 months. One hundred thirty-nine out of 173 (81%) of ICUs collected and sent original data to INICC headquarters, and 34 out of 173 (19%) of ICUs collected and sent aggregated data to INICC headquarters. Original and aggregated data were used to calculate DAI rates. Only original data were used to calculate mortality and lengh of stay.
For the Outcome Surveillance Component, DAI rates, device utilization (DU) ratios, crude excess mortality by specific type of DAI, antimicrobial utilization, and bacterial resistance for January 2003 through December 2008 are summarized (Tables 2-17) . Tables 2-7 show DAI rates and DU ratios by infection type (CLAB, CAUTI, VAP) in adult and pediatric ICUs. The data were not stratified by type or size of hospital.
Device-days consisted of the total number of central linedays, urinary catheter-days, or ventilator-days. The DU ratio constitutes an extrinsic risk factor for HAI. 17 DU also comprises a marker for severity of illness of patients, vis-a-vis, patients' susceptibility to HAI. Tables 8-11 show DAI rates and DU ratios from the High Risk Nursery Component of the INICC system for CLABs and VAPs. For NICUs, device-days consist of the total number of central line-days, umbilical catheter days, and ventilator-days. The data for neonatal ICUs were stratified by weight. Tables 12 and 13 provide data on crude ICU mortality in patients hospitalized in each type of unit during the surveillance period, with and without DAI, and crude excess mortality of adult and pediatric patients with CLAB, CAUTI, and VAP and infants in NICUs with CLAB or VAP. Tables 14 and 15 provide data on crude length of stay of patients hospitalized in each type of unit during the surveillance period with and without DAI and crude excess length of stay of adult and pediatric patients with CLAB, CAUTI, and VAP and infants in NICUs with CLAB or VAP. Table 16 provides data on bacterial resistance of pathogens isolated from patients with DAI in adult and pediatric ICUs and NICUs. Table 17 provides data on hand hygiene compliance in each type of unit. Tables 18 and  19 compare overall rates of CLAB, CAUTI, and VAP (Table  18) 18 and rates of antimicrobial resistance (Table 19) 19 in the INICC and CDC NHSN ICUs.
DISCUSSION
The effectiveness of implementing an integrated infection control program focused on HAI surveillance was demonstrated approximately 30 years ago, as shown in the many studies conducted in the United States, whose results reported not only that the incidence of HAI can be reduced by as much as 30% but that a related reduction in health care costs was also feasible. 20 For more than 30 years, the CDC's NNIS/ NHSN network has provided benchmarking US ICU data on DAIs and antibiotic resistance, which have proven invaluable for researchers, [17] [18] [19] [21] [22] [23] [24] and served as an inspiration to the INICC program. Initially, INICC's surveillance concentrated on DAI surveillance in the ICU, a health care setting with the highest HAI rates and in which patients' safety is most seriously threatened because of their critical condition and exposure to invasive devices. 3 The rate of device use in INICC ICUs is analogous or even lower to the one reported of US ICUs by the NNIS/ NHSN system 18, 24 ; however, DAI rates identified in IN-ICC ICUs are exceedingly higher than the published US rates (Table 18) . 18 Likewise, the antimicrobial resistance rates found in INICC ICUs for Staphylococcus aureus isolates as resistant to methicillin (MRSA), enterobacteria resistant to ceftazidime (extended-spectrum b-lactamase producers), and Pseudomonas aeruginosa as resistant to fluoroquinolones were far higher than NHSN ICUs' rates (Table 19) . 19 Nonetheless, the rates found in the INICC ICUs for enterococcal isolates as resistant to vancomycin is much lower than NHSN ICUs' rates. 19 These higher DAI rates may reflect the typical ICU situation in limited-resources countries as a whole, 25, 26 and several reasons have been exposed to explain this fact. 27 Among the primary plausible causes, it can be mentioned that, in the majority of the limited-resources countries, there are still no legally enforceable rules or regulations concerning the implementation of infection control programs, such as national infection control guidelines; however, in the few cases in which there is a legal framework, adherence to the rules is most irregular, and hospital accreditation is not mandatory. In most INICC hospitals, this lack of official regulations is strongly correlated to the considerable variability found in the compliance with hand hygiene guidelines. This situation is further emphasized by the fact that administrative and financial support in most INICC hospitals is insufficient to fund infection control programs 28 and invariably results in extremely low nurseto-patient staffing ratios (which have proved to be highly connected to high DAI rates in ICUs), 3 hospital overcrowding, lack of medical supplies, and in an insufficient number of experienced nurses or trained health care workers.
According to the World Bank, countries are categorized into 4 economic strata based on 2007 gross [29] [30] [31] [32] [33] Within this categorization, 144 out of 209 (68%) are low income and lower middle income economies, which can also be referred to as lower income countries, low resources countries, developing economies, or developing or emerging countries, representing more than 75% of the world population. The relation between DAI rates and the country socioeconomic level (low income, lower middle income, and high income) and between DAI rates and their association to the type of hospital (public, academic, and private) has not been adequatly analyzed and should therefore be further studied. BSI, bloodstreasm infection; CAUTI, catheter-associated urinary tract infections; CLAB, central line-associated BSI; CLBI, laboratory-confirmed BSI; CSEP, clinical sepsis; VAP, ventilator-associated pneumonia. *Crude excess mortality of DAI 5 crude mortality of ICU patients with DAI 2 crude mortality of patients without HAI. To reduce the hospitalized patients' risk of infection, HAI surveillance is primary and essential because it effectively describes and addresses the importance and characteristics of the threatening situation created by HAIs. This must be followed by the implementation of practices aimed at HAI prevention and control. Additionally, participation in INICC has played a fundamental role not only in increasing the awareness of DAI risks in the INICC ICUs but also providing an exemplary basis for the institution of infection control practices. In many INICC ICUs, for example, the high incidence of HAI has been reduced by carrying out targeted performance feedback programs for hand hygiene and CVC, ventilator, and urinary catheter care. [29] [30] [31] [32] [33] [34] Finally, it is of utmost importance to restrict the administration of anti-infectives to effectively control the increase of antibiotic resistance.
To compare a hospital's HAI rates and DU ratios with the rates identified in this report, it is required that the hospital concerned start by collecting their data by applying the methods and methodology described for CDC NHSN and INICC and then calculate infection rates and DU ratios for the Device-associated Module. The particular and primary applications of these data are to serve as a guide for the implementation of prevention strategies and other quality improvement efforts locally to help reduce HAI rates at the minimum possible level.
In conclusion, the data presented in this report fortify the fact that HAIs, particularly DAIs in ICU patients in limited-resources countries, pose a grave and many times concealed risk to patient safety, as compared with the developed world. It is INICC's main goal to enhance infection control practices, by facilitating elemental, feasible, and inexpensive tools and resources to tackle this problem effectively and systematically, leading to greater and stricter adherence to infection control programs and guidelines, and to the correlated reduction in DAI and its adverse effects, in the ICUs participating in the INICC, as well as at any other health care facility of the developing world.
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